Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2019-02-04Clinical Trial Update: A Study Comparing AC0010 and Chemotherapy in Patients With Advanced NSCLC Who Have Progressed Following Prior EGFR TKI [Phase 3]
The Phase 3 trial comparing AC0010 to standard chemotherapy in advanced non-small cell lung cancer after progression on EGFR inhibitors has …
-
CLINICAL_TRIALS withdrawal · 2019-01-24Clinical Trial Update: Study of Proteins in Tumor Samples From Patients With Non-Small Cell Lung Cancer
The trial studying proteins in tumor samples from patients with non-small cell lung cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2018-07-27Clinical Trial Update: Patient Function/Fitness and Psychosocial Health in Improving Health-Related Quality of Life in Patients With Stage I-IV Non-Small Cell Lung Cancer
This clinical trial update notes that the study evaluating patient function, fitness, and psychosocial health to improve health-related qual…
-
CLINICAL_TRIALS withdrawal · 2018-07-26Clinical Trial Update: Study of Oral cMET Inhibitor INC280 in Chinese Patients With EGFR Wild-type Advanced Non-small Cell Lung Cancer (NSCLC) [Phase 2]
A Phase 2 trial of capmatinib (INC280), a cMET inhibitor, in EGFR wild-type advanced non-small cell lung cancer in Chinese patients has been…
-
CLINICAL_TRIALS withdrawal · 2018-07-05Clinical Trial Update: Evaluation of Lucanthone to Whole Brain Radiation Therapy in Patients With Brain Metastases From Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluating lucanthone in combination with whole-brain radiation therapy for brain metastases from non-small cell lung cancer…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2018-07-05Clinical Trial Update: 18F FLT Imaging Studies of Treatment Response for Lung Cancer and Thymoma [Phase 2]
This document notes the withdrawal of a Phase 2 clinical trial evaluating 18F-FLT PET imaging to monitor treatment response in non-small cel…
-
CLINICAL_TRIALS withdrawal · 2018-07-03Clinical Trial Update: Cryotherapy in Treating Patients With Lung Cancer That Has Spread to the Other Lung or Parts of the Body [NA]
A Wake Forest University Health Sciences-sponsored clinical trial evaluating cryotherapy for metastatic lung cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2018-07-02Clinical Trial Update: Study of Nivolumab Plus Chemotherapy in Patients With Advanced Cancer (NivoPlus) [Phase 1, Phase 2]
The NivoPlus trial evaluating nivolumab plus chemotherapy in various advanced cancers has been terminated (Phase 1/Phase 2).
-
CLINICAL_TRIALS withdrawal · 2018-04-30Clinical Trial Update: An Immuno-Therapy Study of Experimental Medication BMS-986205 Given With Nivolumab With or Without Chemotherapy Compared to Chemotherapy in Participants With Previously Untreated Stage IV or Recurrent Non-Small Cell Lung Cancer [Phase 3]
A Phase 3 trial evaluating BMS-986205 with nivolumab, with or without chemotherapy, versus chemotherapy in previously untreated stage IV or …
-
CLINICAL_TRIALS withdrawal · 2018-04-25Clinical Trial Update: Nivolumab in Treating Patients With Stage IV or Recurrent Lung Cancer With High Mutation Loads [Phase 2]
A Phase 2 trial of nivolumab for patients with Stage IV or recurrent non-small cell lung cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2018-04-17Clinical Trial Update: Pulmonary Interstitial Lymphography in Early Stage Lung Cancer [NA]
The Stanford University-sponsored trial 'Pulmonary Interstitial Lymphography in Early Stage Lung Cancer' has been terminated. The trial stat…
-
CLINICAL_TRIALS withdrawal · 2018-04-17Clinical Trial Update: A Safety Study of Nivolumab in Combination With Ipilimumab in Participants With Advanced Non-small Cell Lung Cancer [Phase 3]
A Phase 3 safety study evaluating nivolumab in combination with ipilimumab for advanced non-small cell lung cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2018-04-02Clinical Trial Update: Endobronchial Ultrasound Guided Transbronchial Needle Aspiration (EBUS-TBNA) for Mediastinal Re-staging of Non-small Cell Lung Cancer(NSCLC) [NA]
A clinical trial evaluating endobronchial ultrasound-guided transbronchial needle aspiration for mediastinal re-staging in non-small cell lu…
-
CLINICAL_TRIALS withdrawal · 2018-03-27Clinical Trial Update: Intervention of Engineered Immune Effector T Cells Against Lung Cancer [Phase 1, Phase 2]
The Phase 1/Phase 2 trial of engineered immune effector T cells for lung cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2018-03-16Clinical Trial Update: MEDI4736 With Selumetinib for KRAS Mutant Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
A Phase 2 trial evaluating durvalumab (MEDI4736) in combination with selumetinib for KRAS-mutant non-small cell lung cancer has been withdra…
-
CLINICAL_TRIALS withdrawal · 2018-03-05Clinical Trial Update: STEREOtactic Radiation and Chemotherapy in Lung Cancer (STEREO) [NA]
The STEREO trial evaluating stereotactic radiation with chemotherapy for non-small cell lung cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2018-02-27Clinical Trial Update: Pacritinib in Patients With Endothelial Growth Factor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC) After EGFR Tyrosine Kinase Inhibitor (TKI) [Phase 1]
Phase 1 trial of pacritinib in EGFR-mutant non-small cell lung cancer after EGFR-TKI has been terminated.
-
CLINICAL_TRIALS withdrawal · 2017-12-06Clinical Trial Update: Durvalumab and Tremelimumab for Adjuvant Therapy of Resected NSCLC [Phase 2]
This Phase 2 trial of durvalumab plus tremelimumab as adjuvant therapy for resected non-small cell lung cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-11-30Clinical Trial Update: Combination of Platinum Doublets and Hypofractionated Radiotherapy in NSCLC [Phase 2]
A phase 2 trial evaluating platinum doublets with hypofractionated radiotherapy for non-small cell lung cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-11-06Clinical Trial Update: Ph2 Nab-paclitaxel With Gemcitabine to Determine Efficacy in Advanced Non-squamous NSCLC. [Phase 2]
A Phase 2 trial evaluating nab-paclitaxel combined with gemcitabine for advanced non-small cell lung cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-08-28Clinical Trial Update: Sym004 in Combination With Nivolumab Versus Nivolumab Monotherapy in EGFR-amplified Squamous Non-Small Cell Lung Cancer [Phase 1, Phase 2]
The clinical trial evaluating Sym004 in combination with nivolumab for EGFR-amplified squamous non-small cell lung cancer has been withdrawn…
-
CLINICAL_TRIALS withdrawal · 2017-08-25Clinical Trial Update: MRI Adaptive Replanning Using ViewRay [NA]
The clinical trial NCT02950792 evaluating MRI adaptive replanning with ViewRay for non-small cell lung cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-08-22Clinical Trial Update: Cyclin B1 Peptide-Pulsed Autologous Dendritic Cell Vaccine for Resectable Non-Small Cell Lung Cancer [NA]
A clinical trial evaluating a cyclin B1 peptide-pulsed autologous dendritic cell vaccine for resectable non-small cell lung cancer has been …
-
CLINICAL_TRIALS withdrawal · 2017-07-31Clinical Trial Update: Vigil™ + Nivolumab in Advanced Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluating Vigil in combination with nivolumab for advanced/metastatic non-small cell lung cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-07-21Clinical Trial Update: Crizotinib Expanded Access Protocol For ROS1 Positive NSCLC
Pfizer's expanded access protocol for crizotinib in ROS1-rearranged non-small cell lung cancer is no longer available.